$YRL $YRL.AX lodged its september quarterly last night and halted for a raise today. $3.3m cash, $6.3m out last quarter. their own estimate: 0.52 quarters of funding. nearly all of it went into the ground: $6.0m on exploration, with a 3,300m diamond program running.
did your director sell before the raise? we checked a year of ASX share placements, 717 companies. at 14 of them, a director sold on market in the 90 days before. of the 10 that sold over $11k, only 4 sold above the raise price. rarer than you'd think.
@Kaizen__8@TuracoGold the acquisition half is out: US$30m cash plus 55.1m shares and 36.7m options. that buys Sodim's 20% of Afema, and it needs a holder vote in dec. raise size not out yet. the sept quarterly had A$47.4m cash.
directors put their own cash into the raise at 129 ASX companies in the past year. most now trade below what they paid.
these ones are well up, price paid to price now:
BOA 2.5c → 11c
BNZ 98.5c → $3.88
OMA 41c → 74c ($8.35m from one director)
ALV 4.9c → 9.5c
DAL 6c → 12c
a week on, 11 of the 17 that raised the week before trade under their raise price. $AV1 placed at 8c and last traded at 5.4c. $DUN is the exception: raised at 4.5c, now 5c.
dilution watch, 19-23 Oct: 10 new ASX raises for $27.1m, the smallest week in a month. $BOA's $9.2m placement was a third of it. and 6 of the 10 didn't say what discount they priced at.
the 4 that did say: $CMG 13% under its last trade. $ADD 11.8% under its close. $MAP 9.1% under its close. $HPC went the other way, its offer 33% over the 5-day average. the 6 that didn't: $BOA $HLX $ZNO $ALB $AEI $VTA.
in a reader poll on what kills confidence in management, directors selling came second. so we counted it.
1,095 ASX share placements in the last year, 717 companies.
at 14 of them a director sold on market in the 90 days before the raise. that's 2%.
flip side: directors bought into their own raise at 129 companies. most of those now trade below what they paid.
neither side tells you much about how the raise ends up.